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Xbstract The Saccharomyces cerevisiae genome sequencing 
project was the first of many projects aimed at sequencing the 
entire genomes of model organisms. Since its initiation in 1989, 
there have been numerous debates about the validity of genome 
~equencing, especially with reference to the model organisms. 
.',;even years on, I hope to satisfy some of the critics by 
demonstrating that, as a consequence of the mass of data now 
becoming available from such projects, and the beginning of the 
major collaborative ffort to sequence the human genome, we are 
now entering an exciting and dynamic time for those involved not 
only in genome sequencing, but also in all areas of the biological 
,ciences. 
l£ey words. Model organism; Genome sequencing; 
~;hotgun sequencing 
I. Introduction 
The concept of sequencing the genomes of model organisms 
-uch as Saccharomyces cerevisiae, (12.5 Mb), Escherichia coli 
,4.7 Mb) and Caenorhabditis elegans (100 Mb) arose at a time 
when tackling the entire human genome seemed beyond the 
,cope of existing technology. Smaller, less complex genomes, 
,ffered the opportunity of developing the technologies re- 
~uired for sequencing the human genome whilst generating 
;_tscinating biological information. The decision to set aside 
~arge amounts of research funding to these projects was con- 
~-oversial. Seen as diverting resources from basic biological 
research, it could only be justified if biological research as a 
whole were seen to benefit. 
2. Historical perspectives 
In 1989, Andre Goffeau set up an EU consortium to se- 
~iuence the genome of the budding yeast S. cerevisiae [1]. 
Many of the 74 laboratories involved were not yeast labora- 
1,)ries, but were drawn to the project in the hope of sequenc- 
ing the homologs of their favourite genes. Most of the lab- 
oratories used a shotgun sequencing approach (Fig. 1) 
involving two stages; an initial 'random' stage of data collec- 
l~on, followed by a directed primer walking stage to complete 
the sequence. The initial random stage can involve the gen- 
eration of clones from whole genomes, or fragments of vari- 
able size (from small restriction fragments to entire chromo- 
somes). In the case of the yeast, most laboratories worked 
fiom Goffeau's map of cosmid and lambda clones [2]. During 
the course of the project shotguns of whole chromosomes 
were attempted [3]. This approach met with problems due 
to difficulties in obtaining sufficiently pure individual chromo- 
somes and was modified to include existing mapped clones 
where available. 
1991 saw the start of four projects aimed at laying the 
foundations for human genome sequencing [4]. Three were 
USA-based projects, (E. coli, S. cerevisiae and Mycoplasma 
capricolum) the fourth (the nematode) was a joint collabora- 
tion between the Cambridge based laboratory of John Sulston 
and Bob Waterston's laboratory at the Washington Univer- 
sity Medical School, St Louis. Table 1 outlines these and 
other model organism projects discussed in this review, and 
the strategies they employ. These include 'shotgun' sequencing 
(used by Fred Sanger to sequence the 48.5 kb bacteriophage 
genome in 1982 [5]) using a range of sources of DNA and 
multiplex walking using genomic DNA [6,7]. The E. coli pilot 
project worked from a physical map of overlapping lambda 
clones [8]. During initial technical developments, nine clones 
(100 kb) were sequenced by subcloning into m13, followed by 
radioactive sequencing. About 75% of the E. coli genome has 
now been completed and is accessible through public data- 
bases (Peter Sterk, personal communication). 
Botstein and Davis also applied shotgun sequencing (using 
fluorescence sequencing machines) to part of the S. cerevisiae 
genome, completing some 1.1 Mb (8.4%) of the genome by 
1995 [1,4]. Gilbert's group used the multiplex walking ap- 
proach for the genome of M. capricolum [6,7]. Direct genome 
sequencing was used to circumvent the effort required in the 
preparation of a physical map and problems of non-random 
genome coverage thought to be associated with the process 
(due to repeats or 'poisonous' genes held within the clones 
[9]). They completed 250000bp by 1995, an impressive total 
for a small laboratory, demonstrating that the multiplex ap- 
proach is applicable to sequencing large chunks of genomic 
DNA. Although direct genome sequencing has been applied 
successfully to a number of simple genomes [10-12] there is a 
worry that the repeats associated with more complex genomes 
may prove intractable to such an approach. 
Each of these projects demonstrated proof of principle in 
terms of technical ability. What they have failed to deliver is 
the scaling-up required to tackle a project the size of the hu- 
man genome. In this respect hey have been largely overshad- 
owed by the evolution of a handful of specialised sequencing 
laboratories. 
Not least of these, J. Craig Venter's laboratory at the In- 
stitute of Genome Research (TIGR), completed the first bac- 
terial genomes; Haemophilus influenzae and M. genitalium for 
which whole genome shotgun sequencing was employed [10- 
12]. As can be seen from Table 1, the majority of current 
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genomic or chromosomal DNA / overlapping clones from physical map 
T 
fragment DNA 
e.g. by physical sheafing, sonication 
or restriction digests 
Subclone into sequencing vectors 
e.g. ml3mpl8 
Random sequencing using universal primers 
either using flourent or radioactive labelling 
assemble overlapping clones to form "contigs" 
directed finishing stage involving custom primers and modified chemistry 
Fig. 1. Stages involved in the 'shotgun' sequencing approach. 
genome projects use shotgun methodology, including that of 
C. elegans. 
The roots of the C. elegans project lie in the collaboration 
between the laboratories of Bob Waterston and John Sulston, 
first to produce the nematode physical map, and then to se- 
quence the genome. The map, which has provided the foun- 
dation of the sequencing project was started by John Sulston 
and Alan Coulson (the map's 'curator') in the mid 1980s. 
Sequencing began in 1991, with a 3 year pilot project o com- 
plete 3 Mb (3%) of the genome. The project was jointly 
funded by the NIH and MRC. One of the first areas to be 
tackled was sequence throughput. 
The aim from the beginning was to scale-up to enable the 
completion of the entire 100 Mb of the nematode genome 
cheaply and efficiently. This has been achieved with very little 
change in basic approach. Improvements made to throughput 
and efficiency have resulted in the reduction of costs from $5 
per base at the beginning, to the present cost of 40 cents per 
finished base. Over the years, all stages have become routine, 
and can be carried out by technical staff trained on site. As 
the experience of our teams has increased, so has output and 
efficiency. All this has been achieved (largely) without any 
significant level of automation, something that will provide 
further improvements in the future. 
These developments were achieved in the first instance 
through the nematode genome, and subsequently expanded 
to include yeast (S. cerevisiae and S. pombe), human, and 
more recently pathogen genomes uch as Mycobacterium tu- 
berculosis and Plasmodium falciparum. Each genome has pres- 
ented a different set of challenges in terms of both sequencing 
chemistry (e.g. GC-rich regions of the human CpG islands, 
and AT-rich sequence of the P. falciparum genome), or soft- 
ware challenges (e.g. handling alu repeats in human). 
In 1992 the Wellcome trust committed to sequence up to 
50% of the yeast genome, involving Bart Barrell's group (San- 
ger Centre) in a substantial expansion of effort. This was 
closely followed by a similar commitment by the NIH, which 
enabled Mark Johnston's group (St Louis) to join the project 
[13], working from Maynard Olsen's physical map [14,15]. 
The involvement of these two laboratories was just the push 
that the project needed; the yeast genome was completed 
early this year with substantial contributions from the EU 
consortium (55%), Sanger Centre (17%), and St Louis 
(10.4%) [1,16]. 
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Fig. 2. Phylogenetic tree in rooted form, showing 3 domains. Branch lengths are based on upon rRNA sequence comparisons. 
/,. The impact of genome sequencing on biologists 
The technological improvements fuelled by the sequencing 
?rojects are already finding their way into other laboratories. 
In addition, there has been a parallel advance in informatics, 
with a view to dealing with the amounts of data generated by 
~uch projects. Although I do not have space to cover this 
~spect in detail here, it must be said that this field has had 
; tremendous impact on the ability of the scientist in the field 
~o both access and use the data available. Apart from this, 
how has all this data helped in our understanding of biology 
~, s a whole? A few examples of the impact of genome sequenc- 
i lg on the scientific ommunity, are given below. 
4. Genome sequencing and phylogeny 
Recent weeks have seen the publication by TIGR of the 
venome sequence of the first archaeon, Methanococcus jan- 
Jaschii [17], presenting scientists with a unique opportunity 
I) compare genomes of organisms from the 3 major branches 
4,f life: archaea, bacteria, and eukarya [17,18]. 
In the late 1970s, Woese used comparison of tRNA se- 
t uences as a means of characterising a number of different 
microbial species [19]. In doing so he discovered a new group 
of organisms which were morphologically prokaryotes, but 
had the RNA profile of eukaryotes [19,20]. This data effec- 
tively split the prokaryotes into the true bacteria (or eubacte- 
ria), and a second group (the archaebacteria) containing the 
methanogenic bacteria, the thermoacidophiles, and the ex- 
treme halophiles. This went against he accepted view of divi- 
sion into prokaryotes (organisms with no nuclear membrane), 
and eukaryotes (organisms with a distinct nuclear membrane) 
[21]. 
The complete sequence of the M. jannaschii genome (1.7 
Mb), yielded some 1734 predicted genes of which 56% had 
no known database similarities. As predicted by Woese, those 
genes with database matches were much more closely related 
to eukaryotic genes than prokaryotic genes, establishing once 
and for all the existence of the third phylogenetic domain 
(Fig. 2). 
5. Inter-specific sequence comparisons and human inherited 
diseases 
Use of sequence homology between distantly related species 
(e.g. hybridisation to zoo-blots) has been used for some time 
"1 able 1 
t ;enome sequencing projects in this review 
~rganism Genome size (Mb) Description Sequencing approach 
3 [. jannaschii 1.7 
3I. genitalium 0.6 
3[. capricolum 0.8 
i ~" influenzae 1.8 
3 [ tuberculosis 4.4 
i .  coli 4.7 
t' falciparum 27 
L'~ cerevisiae 12.5 
,'~ pombe 14 
t ". elegans 1 O0 
D. melanogaster 165 
tL sapiens 3000 
archaea whole genome shotgun 
prokaryote whole genome shotgun 
prokaryote multiplex walking 
prokaryote whole genome shotgun 
prokaryote map, shotgun 
prokaryote map, shotgun 
protozoan whole chromosome+map, shotgun 
single-celled eukaryote map, shotgun 
single-celled eukaryote map, shotgun 
small metazoan map, shotgun 
small metazoan map, directed sequencing 
large metazoan various 
Suppression of 
Cell Death 
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Fig. 3. Programmed cell death in Caenorhabdis elegans. The genes involved in the 
cell or class of cells die. 
nuc- 1 
process of cell death determine whether or not a particular 
to aid the identification of coding sequences. Today, thanks to 
the wealth of genomic and cDNA data, this is possible at the 
sequence level. 
Drosophila melanogaster is a unique model organism, due 
to the high number of well-characterised mutant genes. Infor- 
mation about more than 9000 genes and 25000 alleles is 
held within 'Flybase', which contains information on all as- 
pects of Drosophila genetics and molecular biology [22,23]. 
Despite the evolutionary distance between the human and 
Drosophila, these 2 metazoan genomes how remarkable con- 
servation between genes. Indeed, there are already examples 
of mutations in homologous genes showing similar pheno- 
types in both organisms, as illustrated by the haywire, the 
fly homologue of ERCC3, a human excision repair gene 
that is implicated in Codayne's yndrome and xeroderma pig- 
mentosum [24] 
As a result of the Merck/Washington University expressed 
sequence tag (EST) project there has been a remarkable in- 
crease in the number of human ESTs deposited in the public 
database dbEST [25]. The 343000 entries now include some 
30% previously held in TIGRs private databases. Banff et al. 
[26,27], exploited this remarkable resource, in a systematic 
search for potential human homologues of Drosophila genes 
with known mutant phenotypes. They screened bEST entries 
from the Merck/Washington University consortium for 
matches to Drosophila mutant genes [28]. This approach pro- 
duced some 66 human ESTs, which they called DRES clones 
(Drosophila-Related Express Sequences) which were mapped 
back to the human genome using FISH and mapping [29]. 
The On-line Mendelian Inheritance in Man (OMIM) db was 
used to retrieve information about inherited disease loci 
mapped to the same chromosome in an attempt o identify 
DRES clones that provided positional candidate genes for 
human diseases. 
One example, DRES9, homologous to Drosophila retinal 
degeneration B gene, mapped to 11q13.5, a region to which 
at least 3 types of human retinopathies are assigned. Radia- 
tion mapping data for this clone revealed a link with the 
marker Dl1S913, which showed strong genetic linkage with 
the locus of a retinopathy, Bardet-Biedl syndrome. Another 
example, DRES12 (homologous to the Drosophila eyes absent 
gene), mapped to human chrom 20q 13.1, syntenic with mouse 
chromosome 2;G-H1. Screening of the Dysmorphic Human- 
mouse Homology Database (DHMHD) at the institute of 
Child Health (University of London) revealed that the mouse 
mutant blind-sterile mapped to the same chromosomal region 
[30]. 
The group are now working on the isolation of murine 
homologues to DRESs in order to perform genetic mapping 
and detailed expression studies in the mouse (Banff and Bor- 
sani, personal communication); an elegant demonstration of
how the available information from a number of different 
organisms can be brought ogether to provide a greater under- 
standing of human genetic diseases. 
6. Programmed cell death in Caenorhabditis elegans 
Programmed cell death (apoptosis) plays an important role 
in development of multi-celled organisms. The nematode 6". 
elegans is a key to our understanding of this process. 
The nematode, a simple multicellular organism, is a very 
powerful model system for the study of the cell and molecular 
biology of multicellular animals. It has a well studied devel- 
opment from single-cell to adult, greatly enhanced by its 
transparency, which allows every stage of development to be 
studied in the live animal under Normarski light microscopy. 
Every cell movement, division and death during its develop- 
ment has been determined. During nematode development, 
131 of the 1090 somatic cells of the nematode undergo pro- 
grammed cell death [31,32]. Mutant nematodes with defects in 
these pathways have been identified, along with the gene(s) 
responsible, and this has led to a greater understanding of the 
process of apoptosis. 
The genes involved in this process can be divided into 5 
main groups (Fig. 3), responsible for triggering cell death, 
for the process itself, for engulfment, and finally for the dis- 
posal of the dead cell. Several of the genes involved in the 
pathway have been cloned and sequenced, either directly, or 
as a result of the genome sequencing project, and comparisons 
with homologous genes in other animals are leading to a 
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better understanding of cell death in mammals, ced-9, is re- 
ciuired to prevent activation of apoptosis in C. elegans. Muta- 
tions that cause gain-of function, or over-expression of the 
wild-type ced-9 genes result in the survival of cells that nor- 
l lally die. Mutations reducing ced-9 expression or function, 
auses the death of many cells that normally live, leading to 
t:mbryonic lethality [33]. Clearly, the activities of ced-9 and 
ther cell death genes are essential for normal nematode de- 
elopment. 
Similar genes have been identified in vertebrates and 
,. iruses, including bcl-2 a proto-oncogene which demonstrates 
~', riking functional similarity to ced-9. Over expression of 
I cl-2 protects from cell death, and reduction/loss of function 
auses cells to be hypersensitive to cell death-inducing signals. 
lost striking is the observation that human bcl-2 can prevent 
I rogrammed cell death in C elegans [34]. Sequence compar- 
i,on between the C. elegans ced-9 and mouse bcl-2 shows an 
, verall identity of 24% (49% similarity), bcl-2 belongs to a 
tpidly growing family of genes with similarity to other ced- 
and other nematode cell death genes, ced-3 is homologous 
I~ the interleukin-l[3 converting enzyme (ICE) family of cys- 
I fine proteases in mammals. As yet no known homologues 
I ave been found for ced-4, which contains potential calcium 
1 inding domains, but shows no significant sequence similarity 
I ~ known mammalian proteins; it may be related to an as yet 
i nknown family of mammalian proteins [35] 
The C. elegans apoptosis pathway promises to be particu- 
1 trly useful in highlighting the basic elements of the complex 
i lteracting pathways involved in mammalian apoptosis and 
l ie  identification of the genes involved. 
". Summary 
It is 7 years now since the beginning of the first model 
~ rganism genome sequencing project. Those 7 years have 
s:en the completion of the first bacterial, eukaryotic and ar- 
t haeal genomes. The first metazoan project (the nematode) is
low half-way to completion, and will be complete in 2 years 
I me. We have seen an improvement in the cost and efficiency 
c f genome sequencing to the level at which we can consider 
t tckling the complete human genome. 
Data provided by the model organisms has greatly en- 
Ianced our understanding of many different biological sys- 
t ~'ms, and promises to improve our ability to identify human 
cisease genes. The examples above are wonderful demonstra- 
tons  of how all the resources, be they computational, li- 
1 ~varies, maps or models are now creating a powerful battery 
c f techniques to investigate human genetic diseases and bio- 
l,,gical processes alike 
Far from exhausting their potential, the model organisms 
['~coming increasingly important, and the field is continuing 
I ~ expand, incorporating organisms as diverse as pathogens, 
rlants (Arabidopsis and mice. As more human genomic DNA 
s Nuence becomes available, it is becoming clear that both 
[:momic and est data from all the model organisms, are of 
[:'eat help in predicting coding sequences. Furthermore, se- 
cFuence data from vertebrate genomes uch as the puffer fish 
(Vugu rubripes, [36]) and ultimately the mouse will be invalu- 
a vle. 
Since 1991, mapping of the human genome has moved on 
a~ace, and in May 1995 at the annual Genome mapping and 
s~quencing project at Cold Spring Harbor, the decision was 
made to embark on the complete sequencing of the human 
genome. To this end a large collaborative network has been 
set up with the division of the genome between the established 
large-scale sequencing laboratories. We are entering an excit- 
ing new era, and must conclude that model organism sequenc- 
ing has more that fulfilled its early promise. Hopefully, those 
early critics will now agree. 
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